To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

November 9, 2017

Study Completion Date

November 9, 2017

Conditions

Asthma

Interventions

DRUG

Abediterol

A β2-adrenoceptor agonists, produce smooth muscle relaxation in the airways and improves lung function.

DRUG

Placebo

Abediterol matching placebo without any pharmacological activity.

Trial Locations (1)

Research Site, Berlin